ES8606663A1 - Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestra - Google Patents
Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestraInfo
- Publication number
- ES8606663A1 ES8606663A1 ES541931A ES541931A ES8606663A1 ES 8606663 A1 ES8606663 A1 ES 8606663A1 ES 541931 A ES541931 A ES 541931A ES 541931 A ES541931 A ES 541931A ES 8606663 A1 ES8606663 A1 ES 8606663A1
- Authority
- ES
- Spain
- Prior art keywords
- antibodies
- antigen
- simultaneously detecting
- detecting multiple
- multiple antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/969—Multiple layering of reactants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/819—Multifunctional antigen or antibody
Abstract
UN PROCEDIMIENTO DE ENSAYO INMUNOMETRICO DIRECTO PARA DETECTAR LA PRESENCIA DE AL MENOS DOS ANTIGENOS EN UNA MUESTRA. PUEDEN DETECTARSE AL MENOS DOS ANTIGENOS EN UNA MUESTRA, USANDO UN ENSAYO INMUMOMETRICO SNADWICH DOBLE, QUE CONTIENE UNA CANTIDAD EFICAZ DE AL MENOS UN ANTICUERPO MONOCLONAL CONTRA CADA ANTIGENO, CUYOS ANTICUERPOS ESTAN CONJUGADOS SEPARADAMENTE CON IGUALES O DIFERENTES RESTOS DE SEÑALES COMO MARCADORES, Y UNA CANTIDAD EFICAZ DE AL MENOS UN ANTICUERPO MONOCLONAL SIN MARCAR CONTRA CADA ANTIGENO, CUYOS ANTICUERPOS SIN MARCAR ESTAN INMOVILIZADOS SOBRE UN SOPORTE UNICO. PREFERIBLEMENTE, LOS ANTICUERPOS SON TODOS PRODUCTOS DE DIFERENTES LINAJES CELULARES Y LOS ANTIGENOS SON FOSFATASA DE ACIDO PROSTATICO Y ANTIGENO DE PROSTATA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/596,676 US4690890A (en) | 1984-04-04 | 1984-04-04 | Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay |
Publications (2)
Publication Number | Publication Date |
---|---|
ES541931A0 ES541931A0 (es) | 1986-04-01 |
ES8606663A1 true ES8606663A1 (es) | 1986-04-01 |
Family
ID=24388234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES541931A Expired ES8606663A1 (es) | 1984-04-04 | 1985-04-03 | Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestra |
Country Status (9)
Country | Link |
---|---|
US (1) | US4690890A (es) |
EP (1) | EP0160228A1 (es) |
JP (1) | JPS60228962A (es) |
AU (1) | AU583818B2 (es) |
CA (1) | CA1252388A (es) |
DK (1) | DK155585A (es) |
ES (1) | ES8606663A1 (es) |
IL (1) | IL74796A (es) |
ZA (1) | ZA852574B (es) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0111762B1 (en) * | 1980-06-20 | 1987-11-19 | Unilever Plc | Processes and apparatus for carrying out specific binding assays |
US6406920B1 (en) | 1980-06-20 | 2002-06-18 | Inverness Medical Switzerland Gmbh | Processes and apparatus for carrying out specific binding assays |
US5958790A (en) * | 1984-12-20 | 1999-09-28 | Nycomed Imaging As | Solid phase transverse diffusion assay |
US6200764B1 (en) | 1985-01-29 | 2001-03-13 | Bayer Corporation | Detection, quantitation and classification of ras proteins in body fluids and tissues |
US5443956A (en) * | 1985-01-29 | 1995-08-22 | Oncogene Science, Inc. | Detection, quantitation and classification of RAS proteins in body fluids and tissues |
US5242802A (en) * | 1985-03-29 | 1993-09-07 | Hybritech Incorporated | Processes for the stabilization of prostate specific antigen in natural matrices |
US5153118A (en) * | 1985-12-17 | 1992-10-06 | Eastern Virginia Medical Authority | Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same |
GB8607101D0 (en) * | 1986-03-21 | 1986-04-30 | Serono Diagnostics Ltd | Immunoassay |
GB8614084D0 (en) * | 1986-06-10 | 1986-07-16 | Serono Diagnostics Ltd | Immunoassay |
US4923819A (en) * | 1987-03-27 | 1990-05-08 | Chimerix Corporation | Time-resolved fluorescence immunoassay |
US4788138A (en) * | 1987-04-30 | 1988-11-29 | Beckman Instruments, Inc. | Method to achieve a linear standard curve in a sandwich immunoassay |
AT388618B (de) * | 1987-05-05 | 1989-08-10 | Binder Bernd Dr | Verfahren zur quantitativen bestimmung von funktion und antigener konzentration einer in einer biologischen fluessigkeit enthaltenen substanz |
US6461825B1 (en) * | 1987-09-30 | 2002-10-08 | Sanofi (Societe Anonyme) | Immunometric assay kit and method applicable to whole cells |
GB8801199D0 (en) * | 1988-01-20 | 1988-02-17 | Iq Bio Ltd | Dual enzyme assay |
EP0408658A4 (en) * | 1988-04-04 | 1991-10-02 | Oncor, Inc. | Human papilloma virus typing method and nucleic acid probes used therein |
AU632469B2 (en) * | 1988-04-04 | 1993-01-07 | Johns Hopkins University, The | A method for early detection of lung cancer |
JPH01276068A (ja) * | 1988-04-28 | 1989-11-06 | Kyowa Hakko Kogyo Co Ltd | ヒト癌抗原の定量法 |
EP0438457A1 (en) * | 1988-10-14 | 1991-07-31 | Syntello Ab | A method for simultaneous detection of different types of antibodies and/or antigens produced by individual cells |
US5120662A (en) * | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
DE3919810A1 (de) * | 1989-06-16 | 1990-12-20 | Biochrom Beteiligungs Gmbh & C | Festphasenimmunoassay und testbesteck zur bestimmung von antigenen und antikoerpern |
SE9002480D0 (sv) * | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
JP2555804B2 (ja) * | 1991-07-11 | 1996-11-20 | 日東紡績株式会社 | 前立腺由来酸性ホスファターゼに対するモノクローナル抗体、それを用いた測定法及び測定用キット |
US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
US5447846A (en) * | 1992-07-17 | 1995-09-05 | Fuji Photo Film C., Ltd. | Homogeneous Immunoassay process using covalent conjugate of enzyme and plural monoclonal antibodies for different epitopes on analyte |
GB2269896B (en) * | 1992-08-03 | 1997-03-12 | Marconi Gec Ltd | Separation method |
US5731157A (en) * | 1993-12-30 | 1998-03-24 | The Procter And Gamble Company | Two-site allergen immunoassay |
US5614372A (en) * | 1995-02-24 | 1997-03-25 | Lilja; Hans | Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1) |
US5807978A (en) | 1995-06-07 | 1998-09-15 | Kokolus; William J. | Immunogenic peptides of prostate specific antigen |
SE504798C2 (sv) * | 1995-06-16 | 1997-04-28 | Ulf Landegren | Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten |
JP3981416B2 (ja) * | 1997-04-10 | 2007-09-26 | ユニバーシティ メディカル センター ナイメーヘン | Pca3タンパク質、pca3遺伝子、及びこれらの用途 |
AU7571998A (en) * | 1997-05-14 | 1998-12-08 | Biosite Diagnostics Incorporated | Rapid evaluation of the ratio of biological molecules |
US6569635B1 (en) * | 1998-05-18 | 2003-05-27 | Board Of Regents Of The University Of Nebraska | Growth state-specific immunofluorescent probes for determining physiological state and method of use |
WO2001023550A2 (en) | 1999-09-29 | 2001-04-05 | Diagnocure Inc. | Pca3 messenger rna species in benign and malignant prostate tissues |
US20010026920A1 (en) * | 2000-02-25 | 2001-10-04 | Mark Chandler | Internal standards and controls for multiplexed assay |
US6897024B2 (en) | 2001-05-31 | 2005-05-24 | Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen | Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
US20060177852A1 (en) * | 2001-12-12 | 2006-08-10 | Do-Coop Technologies Ltd. | Solid-fluid composition |
WO2003104820A2 (en) * | 2002-06-10 | 2003-12-18 | Scimed Laboratories Inc. | Extraction and quantification of vitamins a & d in fluid samples |
WO2004070056A2 (en) | 2003-02-07 | 2004-08-19 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
WO2005017485A2 (en) * | 2003-05-22 | 2005-02-24 | Agdia, Inc. | Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes |
WO2005019823A1 (en) * | 2003-08-20 | 2005-03-03 | Celltech R & D Limited | Methods for obtaining antibodies |
US20050186642A1 (en) | 2004-02-24 | 2005-08-25 | Biocare Medical, Inc. | Immunoassay reagents and methods of use thereof |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
US20060223130A1 (en) * | 2005-04-04 | 2006-10-05 | Dan-Hui Yang | Detection of post-translationally modified analytes |
AU2007203960A1 (en) * | 2006-01-04 | 2007-07-12 | Do-Coop Technologies Ltd. | Antiseptic compositions and methods of using same |
US20090253613A1 (en) * | 2006-01-04 | 2009-10-08 | Do-Coop Technologies Ltd. | Solid-Fluid Composition |
US20090004296A1 (en) * | 2006-01-04 | 2009-01-01 | Do-Coop Technologies Ltd. | Antiseptic Compositions and Methods of Using Same |
NZ575827A (en) * | 2006-09-21 | 2012-02-24 | Prometheus Lab Inc | Antibody-based arrays for detecting multiple signal transducers in rare circulating cells |
BRPI0717416A2 (pt) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo |
EP2122350A4 (en) * | 2007-01-04 | 2010-10-27 | Do Coop Technologies Ltd | PROOF OF ANALYTES |
JP2010515432A (ja) * | 2007-01-04 | 2010-05-13 | ドゥ−コープ テクノロジーズ リミテッド | 細胞増殖および細胞融合を高めるための組成物および方法 |
WO2009097425A2 (en) * | 2008-01-29 | 2009-08-06 | Spring Bioscience Corporation | Method for detecting truncated molecules |
ES2398618T3 (es) | 2008-02-25 | 2013-03-20 | Nestec S.A. | Selección de fármacos para terapia del cáncer de mama utilizando matrices de anticuerpos |
US20100136584A1 (en) * | 2008-09-22 | 2010-06-03 | Icb International, Inc. | Methods for using antibodies and analogs thereof |
JP5795311B2 (ja) | 2009-07-15 | 2015-10-14 | ネステク ソシエテ アノニム | 抗体ベースのアレイを使用する胃癌療法のための薬物選択 |
US9719995B2 (en) | 2011-02-03 | 2017-08-01 | Pierian Holdings, Inc. | Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling |
US8852592B2 (en) | 2011-05-10 | 2014-10-07 | Biocare Medical, Llc | Systems and methods for anti-PAX8 antibodies |
EP2751562B1 (en) | 2011-09-02 | 2015-09-16 | Nestec S.A. | Profiling of signal pathway proteins to determine therapeutic efficacy |
US10316103B1 (en) | 2012-03-30 | 2019-06-11 | Biocare Medical, Llc | Systems and methods for anti-Uroplakin III antibodies |
ES2682345T3 (es) | 2012-09-27 | 2018-09-20 | Biocare Medical, Llc | Sistemas y procedimientos de anticuerpos antiuroplaquina II |
WO2014100220A2 (en) | 2012-12-18 | 2014-06-26 | Biocare Medical, Llc | Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer |
WO2014134587A1 (en) | 2013-02-28 | 2014-09-04 | Biocare Medical, Llc | Anti-p40 antibodies systems and methods |
JP6506267B2 (ja) | 2013-10-03 | 2019-04-24 | バイオケア メディカル, エルエルシー | 抗sox10抗体のシステムおよび方法 |
WO2021097685A1 (zh) * | 2019-11-19 | 2021-05-27 | 深圳迈瑞生物医疗电子股份有限公司 | 混合检测PCT和Presepsin的试剂盒、方法以及应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7501215A (nl) * | 1975-02-01 | 1976-08-03 | Akzo Nv | Methode voor het aantonen en bepalen van een antigeen of antilichaam. |
US4207307A (en) * | 1977-01-21 | 1980-06-10 | Research Corporation | Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites |
FI56750C (fi) * | 1978-02-27 | 1980-03-10 | Reijo Vihko | Rekationskaerl foer engaongsbruk vid immunologiskt bestaemning |
IL55816A (en) * | 1978-10-30 | 1982-04-30 | Ames Yissum Ltd | Method for simultaneous immunoassay of several different antibodies and a kit therefor |
EP0042428A4 (en) * | 1979-12-28 | 1982-09-03 | Research Corp | PURIFIED ANTIGEN OF HUMAN PROSTATE. |
US4446122A (en) * | 1979-12-28 | 1984-05-01 | Research Corporation | Purified human prostate antigen |
CA1160566A (en) * | 1980-04-25 | 1984-01-17 | Harald Gallati | Immunological determination method |
EP0044219A1 (en) * | 1980-07-16 | 1982-01-20 | Unilever Plc | Methods of immuno analysis using monoclonal antibodies |
NL185309C (nl) * | 1980-07-28 | 1990-03-01 | Akzo Nv | Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens. |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
SE8006424L (sv) * | 1980-09-12 | 1982-03-13 | Jolla Cancer Res Found | Sett att bestemma ett antigen i losning |
DE3270830D1 (en) * | 1981-01-30 | 1986-06-05 | Centocor Inc | Immunoassay for multi-determinant antigens |
JPS57136165A (en) * | 1981-02-18 | 1982-08-23 | Mochida Pharmaceut Co Ltd | Immunological measuring reagent |
CA1185525A (en) * | 1981-06-22 | 1985-04-16 | Hans J. Hager | Immunochemical assay for prostatic acid phosphatase |
IE54109B1 (en) * | 1982-02-10 | 1989-06-21 | Boots Celltech Diagnostics | Assay |
JPS5984162A (ja) * | 1982-11-05 | 1984-05-15 | Toshiba Corp | 免疫分析法 |
US4474892A (en) * | 1983-02-16 | 1984-10-02 | Board Of Trustees Of The Leland Stanford Junior University | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same |
EP0228243B1 (en) * | 1985-12-17 | 1992-03-25 | Eastern Virginia Medical Authority | Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same |
-
1984
- 1984-04-04 US US06/596,676 patent/US4690890A/en not_active Expired - Fee Related
-
1985
- 1985-01-18 CA CA000472432A patent/CA1252388A/en not_active Expired
- 1985-04-03 EP EP85104012A patent/EP0160228A1/en not_active Withdrawn
- 1985-04-03 DK DK155585A patent/DK155585A/da not_active IP Right Cessation
- 1985-04-03 IL IL74796A patent/IL74796A/xx active IP Right Grant
- 1985-04-03 ES ES541931A patent/ES8606663A1/es not_active Expired
- 1985-04-04 ZA ZA852574A patent/ZA852574B/xx unknown
- 1985-04-04 AU AU40845/85A patent/AU583818B2/en not_active Ceased
- 1985-04-04 JP JP60070172A patent/JPS60228962A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1252388A (en) | 1989-04-11 |
AU4084585A (en) | 1985-10-10 |
ES541931A0 (es) | 1986-04-01 |
DK155585A (da) | 1985-10-05 |
EP0160228A1 (en) | 1985-11-06 |
IL74796A0 (en) | 1985-07-31 |
ZA852574B (en) | 1986-11-26 |
IL74796A (en) | 1989-09-10 |
US4690890A (en) | 1987-09-01 |
AU583818B2 (en) | 1989-05-11 |
DK155585D0 (da) | 1985-04-03 |
JPS60228962A (ja) | 1985-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8606663A1 (es) | Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestra | |
GB8607101D0 (en) | Immunoassay | |
IL69226A0 (en) | Method for determining the presence of an analyte in a sample | |
ZA882998B (en) | Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans | |
EP0158973A3 (en) | Multisite immunometric assay | |
AU2790989A (en) | Method to produce immunodiagnostic reagents | |
CA2130072A1 (en) | Method of detecting a pathogen using a virus | |
DK550288A (da) | Saet samt fremgangsmaade til immunometrisk dosering der kan anvendes paa hele celler | |
EP0113075A3 (en) | Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith | |
CA2077764A1 (en) | Antibody to pacap and use thereof | |
EP0231830A3 (en) | Method of immunochemical assay | |
AU565028B2 (en) | Process using monoclonal antibodies for the determination of pancreatic alpha-amylase | |
ES8701990A1 (es) | Procedimiento para la determinacion de la capacidad de fijacion de la globulina fijadora de tiroxina | |
AU6189486A (en) | Monoclonal antibodies to prosomal proteins | |
ES8606500A1 (es) | Un metodo para determinar la presencia de ige especifica en sueros humanos | |
ES8705232A1 (es) | Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon | |
EP0248147A3 (en) | Method of determining the presence of cancer cells | |
EP0339632A3 (en) | Method of assaying human cancer antigens | |
ES8606501A1 (es) | Un metodo para determinar la presencia de igg especifica en sueros humanos | |
Mazurova et al. | Detection of toxin and the evaluation of the intensity of toxin formation in Corynebacterium diphtheriae by means of the enzyme-linked immunosorbent assay. | |
AU7943091A (en) | Immunological detection methods |